6-bromo-3-(3-(4-bromobenzylideneamino)-1H-1,2,4-triazol-5-yl)-1-ethyl-7-methyl-1,8-naphthyridin-4(1H)-one

ID: ALA4535844

PubChem CID: 155547650

Max Phase: Preclinical

Molecular Formula: C20H16Br2N6O

Molecular Weight: 516.20

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCn1cc(-c2nc(/N=C/c3ccc(Br)cc3)n[nH]2)c(=O)c2cc(Br)c(C)nc21

Standard InChI:  InChI=1S/C20H16Br2N6O/c1-3-28-10-15(17(29)14-8-16(22)11(2)24-19(14)28)18-25-20(27-26-18)23-9-12-4-6-13(21)7-5-12/h4-10H,3H2,1-2H3,(H,25,26,27)/b23-9+

Standard InChI Key:  LYKXNPMNTFASAH-NUGSKGIGSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   24.6712  -11.8286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6700  -12.6481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3781  -13.0571    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3763  -11.4197    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0849  -11.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0856  -12.6440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7942  -13.0511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.5024  -12.6403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.4977  -11.8181    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7886  -11.4148    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9620  -13.0562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7959  -13.8683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0890  -14.2783    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7843  -10.5976    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.2020  -11.4028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9506  -11.7306    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.4937  -11.1200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0808  -10.4148    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.2825  -10.5897    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.3104  -11.1188    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.7179  -10.4104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5350  -10.4091    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9437  -11.1177    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7602  -11.1168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1685  -10.4079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7544   -9.6985    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.9393   -9.7029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9633  -11.4202    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   33.9857  -10.4055    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10  5  1  0
  2 11  1  0
  7 12  1  0
 12 13  1  0
 10 14  2  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 15  1  0
  9 15  1  0
 17 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  1 28  1  0
 25 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4535844

    ---

Associated Targets(non-human)

Staphylococcus aureus (210822 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Bacillus subtilis (32866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Escherichia coli (133304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Pseudomonas aeruginosa (123386 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycolicibacterium phlei (631 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Aggregatibacter actinomycetemcomitans (150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
gyrB DNA gyrase (2092 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 516.20Molecular Weight (Monoisotopic): 513.9752AlogP: 4.79#Rotatable Bonds: 4
Polar Surface Area: 88.82Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 6.84CX Basic pKa: 3.16CX LogP: 5.40CX LogD: 4.78
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.40Np Likeness Score: -1.14

References

1. Zhang J, Wang S, Ba Y, Xu Z..  (2019)  1,2,4-Triazole-quinoline/quinolone hybrids as potential anti-bacterial agents.,  174  [PMID:31015103] [10.1016/j.ejmech.2019.04.033]
2. Dighe SN, Collet TA..  (2020)  Recent advances in DNA gyrase-targeted antimicrobial agents.,  199  [PMID:32460040] [10.1016/j.ejmech.2020.112326]
3. Aggarwal R, Sumran G..  (2020)  An insight on medicinal attributes of 1,2,4-triazoles.,  205  [PMID:32771798] [10.1016/j.ejmech.2020.112652]

Source